Introduction Innate Pharma

Skip to main content. Subscribe to email alerts. Innate Pharma, the innate immunity company. A reference technology monoclonal antibodies. Lirilumab anti-KIR mAb licensed to Bristol-Myers Squibb. Monalizumab first-in-class anti-NKG2A mAb, partnered with AstraZeneca and MedImmune. IPH52 Anti-CD39 mAb program. Financial Calendar for 2016. Number of shares and voting rights. Share repurchase liquidity agreement. General Shareholders Meeting documents. Annual general meeting documents 2016. First clini.

OVERVIEW

The domain innate-pharma.com presently has a traffic classification of zero (the lower the more traffic). We have parsed twenty-two pages within the web site innate-pharma.com and found seventy-eight websites referencing innate-pharma.com. We have acquired three contacts and directions for innate-pharma.com to help you communicate with them. We have acquired two mass communication sites owned by innate-pharma.com. The domain innate-pharma.com has been online for nine hundred and fifty-five weeks, twenty-two days, nine hours, and twelve minutes.
Pages Parsed
22
Links to this site
78
Contacts
3
Addresses
3
Social Links
2
Online Since
May 2006

INNATE-PHARMA.COM TRAFFIC

The domain innate-pharma.com is seeing alternating quantities of traffic all round the year.
Traffic for innate-pharma.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for innate-pharma.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for innate-pharma.com

Date Range

All time
This Year
Last Year
Last Month

INNATE-PHARMA.COM HISTORY

The domain innate-pharma.com was first documented on May 22, 2006. This web site was updated on the date of April 16, 2013. This website will expire on the date of April 20, 2015. It is currently nine hundred and fifty-five weeks, twenty-two days, nine hours, and twelve minutes old.
REGISTERED
May
2006
UPDATED
April
2013
EXPIRED
April
2015

WEBSITE PERIOD OF EXISTANCE

18
YEARS
3
MONTHS
21
DAYS

LINKS TO WEBSITE

Institut Carnot CALYM Consortium de recherche académique sur le lymphome

Et de son transfert dans le domaine du lymphome. Collection de cellules vivantes - CeVi.

Le blog du magazine DocteursCo

et pas uniquement! Cette fois-ci, nous y sommes pour de vrai vraiment. Je laisse mes chers collègues. Je vous laisse ce blog. Paul Besançon, le DR.

French Biotechs

Friday, April 11, 2014. PDF Communiqué de Presse Guerbet. Publié par Benjamin de Bélizal.

WHAT DOES INNATE-PHARMA.COM LOOK LIKE?

Desktop Screenshot of innate-pharma.com Mobile Screenshot of innate-pharma.com Tablet Screenshot of innate-pharma.com

CONTACTS

INNATE PHARMA SA

117 Avenue De Luminy

MARSEILLE, 13009

FR

INNATE PHARMA SA

INNATE PHARMA SA

117 Avenue De Luminy

null, null, null

FR

AMEN.FR

AMEN.FR

12-14, Rond Point des Champs Elysees

Paris, France, 75008

FR

INNATE-PHARMA.COM SERVER

I revealed that the main root page on innate-pharma.com took eight hundred and forty-four milliseconds to load. I could not observe a SSL certificate, so therefore our parsers consider innate-pharma.com not secure.
Load time
0.844 sec
SSL
NOT SECURE
IP
176.31.83.193

NAME SERVERS

ns1.amen.fr
ns2.amen.fr

WEBSITE ICON

SERVER SOFTWARE

We observed that innate-pharma.com is implementing the Apache os.

SITE TITLE

Introduction Innate Pharma

DESCRIPTION

Skip to main content. Subscribe to email alerts. Innate Pharma, the innate immunity company. A reference technology monoclonal antibodies. Lirilumab anti-KIR mAb licensed to Bristol-Myers Squibb. Monalizumab first-in-class anti-NKG2A mAb, partnered with AstraZeneca and MedImmune. IPH52 Anti-CD39 mAb program. Financial Calendar for 2016. Number of shares and voting rights. Share repurchase liquidity agreement. General Shareholders Meeting documents. Annual general meeting documents 2016. First clini.

PARSED CONTENT

The domain had the following in the web site, "Innate Pharma, the innate immunity company." I analyzed that the web site stated " A reference technology monoclonal antibodies." They also stated " Lirilumab anti-KIR mAb licensed to Bristol-Myers Squibb. Monalizumab first-in-class anti-NKG2A mAb, partnered with AstraZeneca and MedImmune. Number of shares and voting rights. Annual general meeting documents 2016."

SEE OTHER BUSINESSES

innate-style.com - Daily Fashion News Breaking Latest Stories

How Designer Pia Arrobio Packs for Vacation. The 20 Best Bags of NYFW Street Style, and Where You Can Buy Them. How Designer Pia Arrobio Packs for Vacation. When California designer Pia Arrobio launched her new label LPA last year, she had an instant hit on her hands.

Innate Enterprise Your Partner in Growth

Strategic Growth Partners Since 2011. Strategic Growth Partners Since 2011. We work with our customer to discover their challenges and understand what opportunities exist within the market. We help them define competitive advantage and long term objectives. A creative, well planned and executable strategy is necessary for the greatest return on investment. Our team of industry experts will transform the plan into real business project.

www.INNATE.com

We Proudly Carry The Entire Lineup of. Click HERE for all Wizards Products.

Membership Options innate

You must login to see this website content .